Spots Global Cancer Trial Database for Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer
Official Title: Phase I Assessment of NO Mediated Signaling in Cancer Cachexia
Study ID: NCT02106871
Interventions
Study Description
Brief Summary: Investigation of the effects of daily sildenafil on patients with pancreatic or cholangiocarcinoma cancer undergoing treatment.
Detailed Description: This is a double-blinded, placebo-controlled trial in men and women, 40-75 years old, diagnosed with pancreatic or cholangiocarcinoma cancer. Patients will receive placebo or sildenafil daily for 4 weeks during their initial chemotherapy cycle.
Eligibility
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The University of Texas Medical Branch, Galveston, Texas, United States
Contact Details
Name: Melinda Sheffield-Moore, PhD
Affiliation: University of Texas
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
